Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Int J Rheum Dis. 2019 May;22(5):789-796. doi: 10.1111/1756-185X.13422. Epub 2018 Nov 5.
We investigated the impact of renal involvement at diagnosis on the prognosis of patients with antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
The relationship between renal involvement at diagnosis, clinical variables at diagnosis, and prognosis (including relapse episodes, initiation of dialysis, and death) was examined in 101 Japanese patients with AAV.
Sixty-eight patients had renal involvement at diagnosis. The renal-involvement patients had significantly higher ages at diagnosis, significantly lower hemoglobin levels, and significantly lower platelet levels. They had significantly lower C3 levels, but showed no significant difference in C4 levels. Overall survival rate was significantly worse in patients with than in patients without renal involvement (P = 0.003, log-rank test). Multivariable analysis using a logistic regression model demonstrated that C3 contributed to dialysis initiation: odds ratio (per 10 mg/dL of C3): 0.68; range: 0.49-0.90; P = 0.007. A Cox proportional hazard model revealed that the C3 level and age at diagnosis contributed significantly to overall survival: hazard ratio (per 10 mg/dL of C3) 0.81, range 0.69-0.95, P = 0.011; 1.08, 1.02-1.15, P = 0.013, respectively. Renal involvement did not contribute significantly to overall survival. Patients with C3 levels ≥100 mg/dL had a better survival rate than patients with C3 levels <100 mg/dL.
Although patients with renal involvement had higher ages, lower C3 levels at diagnosis, and poorer prognoses, multivariable analysis demonstrated that the C3 level and age at diagnosis, but not renal involvement, contributed significantly to overall survival. Our results demonstrate the relationship between C3 hidden behind renal involvement and AAV prognosis.
我们研究了诊断时的肾脏受累对抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)患者预后的影响。
我们检查了 101 例日本 AAV 患者的诊断时的肾脏受累、诊断时的临床变量与预后(包括复发、开始透析和死亡)之间的关系。
68 例患者在诊断时存在肾脏受累。与无肾脏受累的患者相比,肾脏受累患者的年龄明显更大,血红蛋白水平明显更低,血小板水平明显更低。他们的 C3 水平明显较低,但 C4 水平没有显著差异。总体生存率在有肾脏受累的患者中明显差于无肾脏受累的患者(P=0.003,对数秩检验)。使用逻辑回归模型的多变量分析表明,C3 与透析开始有关:每增加 10mg/dL 的 C3 的比值比(OR):0.68;范围:0.49-0.90;P=0.007。Cox 比例风险模型显示,C3 水平和诊断时的年龄对总生存率有显著影响:每增加 10mg/dL 的 C3 的风险比(HR)为 0.81,范围为 0.69-0.95,P=0.011;1.08,1.02-1.15,P=0.013。肾脏受累对总生存率没有显著影响。C3 水平≥100mg/dL 的患者的生存率高于 C3 水平<100mg/dL 的患者。
尽管肾脏受累的患者年龄更大,诊断时的 C3 水平更低,预后更差,但多变量分析表明,C3 水平和诊断时的年龄,而不是肾脏受累,对总生存率有显著影响。我们的结果表明了 C3 隐藏在肾脏受累背后与 AAV 预后之间的关系。